Pharma Mar, S.A. (BME:PHM)

Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	17.82	63.24	60.02	143.78	113.35
Short-Term Investments	149.41	91.29	102.54	32.4	88.53
Cash & Short-Term Investments	167.22	154.53	162.56	176.17	201.88
Cash Growth	8.22%	-4.94%	-7.73%	-12.73%	3.26%
Accounts Receivable	39.41	34.68	27.55	55.76	50.91
Other Receivables	21.19	7.33	20.28	-	-
Total Trade Receivables	60.6	42.01	47.83	55.76	50.91
Inventory	54.1	51.97	39.29	26.93	10.54
Other Current Assets	1.5	1.74	2.92	5.87	31.91
Total Current Assets	283.42	250.25	252.6	264.74	295.23
Net Property, Plant & Equipment	61	59.93	48.45	30.16	31.45
Other Intangible Assets	3.55	1	1.94	2.33	3.23
Long-Term Investments	0.58	2.46	6.06	134.94	10.72
Other Long-Term Assets	46.55	36.01	31.47	22.5	27.75
Total Assets	395.08	349.64	340.52	454.67	368.39

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	54.34	51.58	40.3	81.15	29.27
Accrued Expenses	3.02	3.35	3.4	-	-
Current Portion of Long-Term Debt	11.03	7.97	12.83	8.79	12.21
Current Portion of Leases	1.71	1.88	1.98	-	1.82
Unearned Revenue	6.78	3.97	24.93	24.66	29.67
Other Current Liabilities	17.01	13.94	12.46	15.16	13.38
Total Current Liabilities	93.88	82.69	95.89	92.26	86.35
Long-Term Debt	35.55	39.87	27.04	25.03	33.39
Long-Term Leases	1.13	1.36	1.83	-	1.92
Other Long-Term Liabilities	12.69	17.36	22.33	44.33	68.82
Total Long-Term Liabilities	49.37	58.59	51.19	69.36	104.12
Total Liabilities	143.25	141.29	147.08	161.62	190.47

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	10.8	10.93	11.01	11.01	11.01
Treasury Stock	-38.72	-30.83	-31.09	-15.87	-25.68
Additional Paid-in Capital	45.91	59.86	71.28	71.28	71.28
Accumulated Other Comprehensive Income	0.02	0.02	0.02	1	0.02
Retained Earnings	233.83	168.38	142.22	508.64	121.29
Shareholders' Equity	251.83	208.36	193.44	576.07	177.92
Total Liabilities & Equity	395.08	349.64	340.52	454.67	368.39

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	49.42	51.08	43.67	33.82	49.33
Net Cash (Debt)	117.81	103.45	118.89	142.35	152.55
Net Cash Growth	13.88%	-12.99%	-16.48%	-6.68%	9.86%
Net Cash Per Share	6.75	5.89	6.64	7.88	8.44
Book Value	251.83	208.36	193.44	576.07	177.92
Book Value Per Share	14.43	11.86	10.80	31.89	9.84
Tangible Book Value	248.29	207.36	191.5	573.74	174.69
Tangible Book Value Per Share	14.23	11.81	10.69	31.76	9.66

Data Source: Fiscal.ai Last updated: Feb 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error